APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felbamate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Felbamate Market Analysis and Forecast 2026-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchFelbamate Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Felbamate Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Felbamate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felbamate Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Felbamate Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Felbamate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Felbamate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Felbamate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Felbamate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Felbamate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Felbamate include Sun Pharma, Mylan, Schering Plough, Merck Sharp and Dohme, Corepharma, Cadila Healthcare, ANI Pharmaceuticals, Amneal Pharmaceuticals and Alvogen, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Felbamate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Felbamate, also provides the sales of main regions and countries. Of the upcoming market potential for Felbamate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Felbamate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Felbamate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Felbamate sales, projected growth trends, production technology, application and end-user industry.

Felbamate Segment by Company

Sun Pharma

Mylan

Schering Plough

Merck Sharp and Dohme

Corepharma

Cadila Healthcare

ANI Pharmaceuticals

Amneal Pharmaceuticals

Alvogen

Felbamate Segment by Type

Tablet

Oral Solution

Felbamate Segment by Application

Refractory Lennox-Gastaut Syndrome

Refractory Seizure Disorders

Others

Felbamate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felbamate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felbamate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felbamate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Felbamate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Felbamate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Felbamate sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Felbamate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Manufacturers Table 3. Oral Solution Major Manufacturers Table 4. Global Felbamate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Refractory Lennox-Gastaut Syndrome Major Manufacturers Table 6. Refractory Seizure Disorders Major Manufacturers Table 7. Others Major Manufacturers Table 8. Felbamate Industry Trends Table 9. Felbamate Industry Drivers Table 10. Felbamate Industry Opportunities and Challenges Table 11. Felbamate Industry Restraints Table 12. Global Felbamate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Felbamate Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Felbamate Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Felbamate Revenue Market Share by Region (2021-2026) Table 16. Global Felbamate Revenue Market Share by Region (2027-2032) Table 17. Global Felbamate Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Felbamate Sales by Region (2021-2026) & (K Units) Table 19. Global Felbamate Sales by Region (2027-2032) & (K Units) Table 20. Global Felbamate Sales Market Share by Region (2021-2026) Table 21. Global Felbamate Sales Market Share by Region (2027-2032) Table 22. Global Felbamate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Felbamate Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Felbamate Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Felbamate Sales Market Share by Manufacturers (2021-2026) Table 26. Global Felbamate Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Felbamate Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Felbamate Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Felbamate Manufacturers, Product Type & Application Table 30. Global Felbamate Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Felbamate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Felbamate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Felbamate Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Felbamate Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Felbamate Revenue Market Share by Type (2021-2026) Table 37. Global Felbamate Revenue Market Share by Type (2027-2032) Table 38. Global Felbamate Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Felbamate Sales by Type (2021-2026) & (K Units) Table 40. Global Felbamate Sales by Type (2027-2032) & (K Units) Table 41. Global Felbamate Sales Market Share by Type (2021-2026) Table 42. Global Felbamate Sales Market Share by Type (2027-2032) Table 43. Global Felbamate Price by Type (2021-2026) & (US$/Unit) Table 44. Global Felbamate Price by Type (2027-2032) & (US$/Unit) Table 45. Global Felbamate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Felbamate Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Felbamate Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Felbamate Revenue Market Share by Application (2021-2026) Table 49. Global Felbamate Revenue Market Share by Application (2027-2032) Table 50. Global Felbamate Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Felbamate Sales by Application (2021-2026) & (K Units) Table 52. Global Felbamate Sales by Application (2027-2032) & (K Units) Table 53. Global Felbamate Sales Market Share by Application (2021-2026) Table 54. Global Felbamate Sales Market Share by Application (2027-2032) Table 55. Global Felbamate Price by Application (2021-2026) & (US$/Unit) Table 56. Global Felbamate Price by Application (2027-2032) & (US$/Unit) Table 57. Sun Pharma Company Information Table 58. Sun Pharma Business Overview Table 59. Sun Pharma Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Sun Pharma Felbamate Product Portfolio Table 61. Sun Pharma Recent Development Table 62. Mylan Company Information Table 63. Mylan Business Overview Table 64. Mylan Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Mylan Felbamate Product Portfolio Table 66. Mylan Recent Development Table 67. Schering Plough Company Information Table 68. Schering Plough Business Overview Table 69. Schering Plough Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Schering Plough Felbamate Product Portfolio Table 71. Schering Plough Recent Development Table 72. Merck Sharp and Dohme Company Information Table 73. Merck Sharp and Dohme Business Overview Table 74. Merck Sharp and Dohme Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Merck Sharp and Dohme Felbamate Product Portfolio Table 76. Merck Sharp and Dohme Recent Development Table 77. Corepharma Company Information Table 78. Corepharma Business Overview Table 79. Corepharma Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Corepharma Felbamate Product Portfolio Table 81. Corepharma Recent Development Table 82. Cadila Healthcare Company Information Table 83. Cadila Healthcare Business Overview Table 84. Cadila Healthcare Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Cadila Healthcare Felbamate Product Portfolio Table 86. Cadila Healthcare Recent Development Table 87. ANI Pharmaceuticals Company Information Table 88. ANI Pharmaceuticals Business Overview Table 89. ANI Pharmaceuticals Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. ANI Pharmaceuticals Felbamate Product Portfolio Table 91. ANI Pharmaceuticals Recent Development Table 92. Amneal Pharmaceuticals Company Information Table 93. Amneal Pharmaceuticals Business Overview Table 94. Amneal Pharmaceuticals Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Amneal Pharmaceuticals Felbamate Product Portfolio Table 96. Amneal Pharmaceuticals Recent Development Table 97. Alvogen Company Information Table 98. Alvogen Business Overview Table 99. Alvogen Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Alvogen Felbamate Product Portfolio Table 101. Alvogen Recent Development Table 102. North America Felbamate Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Felbamate Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Felbamate Sales by Type (2021-2026) & (K Units) Table 105. North America Felbamate Sales by Type (2027-2032) & (K Units) Table 106. North America Felbamate Sales Price by Type (2021-2026) & (US$/Unit) Table 107. North America Felbamate Sales Price by Type (2027-2032) & (US$/Unit) Table 108. North America Felbamate Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Felbamate Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Felbamate Sales by Application (2021-2026) & (K Units) Table 111. North America Felbamate Sales by Application (2027-2032) & (K Units) Table 112. North America Felbamate Sales Price by Application (2021-2026) & (US$/Unit) Table 113. North America Felbamate Sales Price by Application (2027-2032) & (US$/Unit) Table 114. North America Felbamate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Felbamate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Felbamate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Felbamate Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. North America Felbamate Sales by Country (2021-2026) & (K Units) Table 119. North America Felbamate Sales by Country (2027-2032) & (K Units) Table 120. North America Felbamate Sales Price by Country (2021-2026) & (US$/Unit) Table 121. North America Felbamate Sales Price by Country (2027-2032) & (US$/Unit) Table 122. United States Felbamate Revenue (2021-2032) & (US$ Million) Table 123. Canada Felbamate Revenue (2021-2032) & (US$ Million) Table 124. Europe Felbamate Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Felbamate Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Felbamate Sales by Type (2021-2026) & (K Units) Table 127. Europe Felbamate Sales by Type (2027-2032) & (K Units) Table 128. Europe Felbamate Sales Price by Type (2021-2026) & (US$/Unit) Table 129. Europe Felbamate Sales Price by Type (2027-2032) & (US$/Unit) Table 130. Europe Felbamate Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Felbamate Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Felbamate Sales by Application (2021-2026) & (K Units) Table 133. Europe Felbamate Sales by Application (2027-2032) & (K Units) Table 134. Europe Felbamate Sales Price by Application (2021-2026) & (US$/Unit) Table 135. Europe Felbamate Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Europe Felbamate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Felbamate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Felbamate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Felbamate Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 140. Europe Felbamate Sales by Country (2021-2026) & (K Units) Table 141. Europe Felbamate Sales by Country (2027-2032) & (K Units) Table 142. Europe Felbamate Sales Price by Country (2021-2026) & (US$/Unit) Table 143. Europe Felbamate Sales Price by Country (2027-2032) & (US$/Unit) Table 144. Germany Felbamate Revenue (2021-2032) & (US$ Million) Table 145. France Felbamate Revenue (2021-2032) & (US$ Million) Table 146. U.K. Felbamate Revenue (2021-2032) & (US$ Million) Table 147. Italy Felbamate Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Felbamate Revenue (2021-2032) & (US$ Million) Table 149. China Felbamate Revenue by Type (2021-2026) & (US$ Million) Table 150. China Felbamate Revenue by Type (2027-2032) & (US$ Million) Table 151. China Felbamate Sales by Type (2021-2026) & (K Units) Table 152. China Felbamate Sales by Type (2027-2032) & (K Units) Table 153. China Felbamate Sales Price by Type (2021-2026) & (US$/Unit) Table 154. China Felbamate Sales Price by Type (2027-2032) & (US$/Unit) Table 155. China Felbamate Revenue by Application (2021-2026) & (US$ Million) Table 156. China Felbamate Revenue by Application (2027-2032) & (US$ Million) Table 157. China Felbamate Sales by Application (2021-2026) & (K Units) Table 158. China Felbamate Sales by Application (2027-2032) & (K Units) Table 159. China Felbamate Sales Price by Application (2021-2026) & (US$/Unit) Table 160. China Felbamate Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia Felbamate Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Felbamate Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Felbamate Sales by Type (2021-2026) & (K Units) Table 164. Asia Felbamate Sales by Type (2027-2032) & (K Units) Table 165. Asia Felbamate Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Asia Felbamate Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Asia Felbamate Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Felbamate Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Felbamate Sales by Application (2021-2026) & (K Units) Table 170. Asia Felbamate Sales by Application (2027-2032) & (K Units) Table 171. Asia Felbamate Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Asia Felbamate Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Asia Felbamate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Felbamate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Felbamate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Felbamate Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. Asia Felbamate Sales by Country (2021-2026) & (K Units) Table 178. Asia Felbamate Sales by Country (2027-2032) & (K Units) Table 179. Asia Felbamate Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Asia Felbamate Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Japan Felbamate Revenue (2021-2032) & (US$ Million) Table 182. South Korea Felbamate Revenue (2021-2032) & (US$ Million) Table 183. India Felbamate Revenue (2021-2032) & (US$ Million) Table 184. Australia Felbamate Revenue (2021-2032) & (US$ Million) Table 185. China Taiwan Felbamate Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Felbamate Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Felbamate Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Felbamate Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Felbamate Sales by Type (2021-2026) & (K Units) Table 190. SAMEA Felbamate Sales by Type (2027-2032) & (K Units) Table 191. SAMEA Felbamate Sales Price by Type (2021-2026) & (US$/Unit) Table 192. SAMEA Felbamate Sales Price by Type (2027-2032) & (US$/Unit) Table 193. SAMEA Felbamate Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Felbamate Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Felbamate Sales by Application (2021-2026) & (K Units) Table 196. SAMEA Felbamate Sales by Application (2027-2032) & (K Units) Table 197. SAMEA Felbamate Sales Price by Application (2021-2026) & (US$/Unit) Table 198. SAMEA Felbamate Sales Price by Application (2027-2032) & (US$/Unit) Table 199. SAMEA Felbamate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Felbamate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Felbamate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Felbamate Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 203. SAMEA Felbamate Sales by Country (2021-2026) & (K Units) Table 204. SAMEA Felbamate Sales by Country (2027-2032) & (K Units) Table 205. SAMEA Felbamate Sales Price by Country (2021-2026) & (US$/Unit) Table 206. SAMEA Felbamate Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Brazil Felbamate Revenue (2021-2032) & (US$ Million) Table 208. Argentina Felbamate Revenue (2021-2032) & (US$ Million) Table 209. Chile Felbamate Revenue (2021-2032) & (US$ Million) Table 210. Colombia Felbamate Revenue (2021-2032) & (US$ Million) Table 211. Peru Felbamate Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Felbamate Revenue (2021-2032) & (US$ Million) Table 213. Israel Felbamate Revenue (2021-2032) & (US$ Million) Table 214. UAE Felbamate Revenue (2021-2032) & (US$ Million) Table 215. Turkey Felbamate Revenue (2021-2032) & (US$ Million) Table 216. Iran Felbamate Revenue (2021-2032) & (US$ Million) Table 217. Egypt Felbamate Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Felbamate Distributors List Table 221. Felbamate Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Felbamate Image Figure 2. Global Felbamate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felbamate Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Oral Solution Image Figure 6. Global Felbamate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Felbamate Market Size Share 2021 VS 2025 VS 2032 Figure 8. Refractory Lennox-Gastaut Syndrome Image Figure 9. Refractory Seizure Disorders Image Figure 10. Others Image Figure 11. Global Felbamate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Felbamate Revenue (2021-2032) & (US$ Million) Figure 13. Global Felbamate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Felbamate Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Felbamate Revenue Market Share by Region (2021-2032) Figure 16. Global Felbamate Sales (2021-2032) & (K Units) Figure 17. Global Felbamate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Felbamate Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Felbamate Sales YoY (2021-2032) & (K Units) Figure 20. Europe Felbamate Sales YoY (2021-2032) & (K Units) Figure 21. China Felbamate Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Felbamate Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Felbamate Sales YoY (2021-2032) & (K Units) Figure 24. Global Felbamate Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Felbamate Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Felbamate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Felbamate Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Felbamate Revenue Market Share by Type (2021-2032) Figure 30. Global Felbamate Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Felbamate Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Felbamate Sales Market Share by Type (2021-2032) Figure 33. Global Felbamate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Felbamate Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Felbamate Revenue Market Share by Application (2021-2032) Figure 36. Global Felbamate Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Felbamate Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Felbamate Sales Market Share by Application (2021-2032) Figure 39. North America Felbamate Revenue Share by Type (2021-2032) Figure 40. North America Felbamate Sales Share by Type (2021-2032) Figure 41. North America Felbamate Revenue Share by Application (2021-2032) Figure 42. North America Felbamate Sales Share by Application (2021-2032) Figure 43. North America Felbamate Revenue Share by Country (2021-2032) Figure 44. North America Felbamate Sales Share by Country (2021-2032) Figure 45. Europe Felbamate Revenue Share by Type (2021-2032) Figure 46. Europe Felbamate Sales Share by Type (2021-2032) Figure 47. Europe Felbamate Revenue Share by Application (2021-2032) Figure 48. Europe Felbamate Sales Share by Application (2021-2032) Figure 49. Europe Felbamate Revenue Share by Country (2021-2032) Figure 50. Europe Felbamate Sales Share by Country (2021-2032) Figure 51. China Felbamate Revenue Share by Type (2021-2032) Figure 52. China Felbamate Sales Share by Type (2021-2032) Figure 53. China Felbamate Revenue Share by Application (2021-2032) Figure 54. China Felbamate Sales Share by Application (2021-2032) Figure 55. Asia Felbamate Revenue Share by Type (2021-2032) Figure 56. Asia Felbamate Sales Share by Type (2021-2032) Figure 57. Asia Felbamate Revenue Share by Application (2021-2032) Figure 58. Asia Felbamate Sales Share by Application (2021-2032) Figure 59. Asia Felbamate Revenue Share by Country (2021-2032) Figure 60. Asia Felbamate Sales Share by Country (2021-2032) Figure 61. SAMEA Felbamate Revenue Share by Type (2021-2032) Figure 62. SAMEA Felbamate Sales Share by Type (2021-2032) Figure 63. SAMEA Felbamate Revenue Share by Application (2021-2032) Figure 64. SAMEA Felbamate Sales Share by Application (2021-2032) Figure 65. SAMEA Felbamate Revenue Share by Country (2021-2032) Figure 66. SAMEA Felbamate Sales Share by Country (2021-2032) Figure 67. Felbamate Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Felbamate Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Solution
Applications
  • Refractory Lennox-Gastaut Syndrome
  • Refractory Seizure Disorders
  • Others
Companies covered
  • Sun Pharma
  • Mylan
  • Schering Plough
  • Merck Sharp and Dohme
  • Corepharma
  • Cadila Healthcare
  • ANI Pharmaceuticals
  • Amneal Pharmaceuticals
  • Alvogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Felbamate Market by Type
  3. 1.2.1 Global Felbamate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Oral Solution
  6. 1.3 Felbamate Market by Application
  7. 1.3.1 Global Felbamate Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Refractory Lennox-Gastaut Syndrome
  9. 1.3.3 Refractory Seizure Disorders
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Felbamate Market Dynamics
  1. 2.1 Felbamate Industry Trends
  2. 2.2 Felbamate Industry Drivers
  3. 2.3 Felbamate Industry Opportunities and Challenges
  4. 2.4 Felbamate Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Felbamate Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Felbamate Revenue by Region
  3. 3.2.1 Global Felbamate Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Felbamate Revenue by Region (2021-2026)
  5. 3.2.3 Global Felbamate Revenue by Region (2027-2032)
  6. 3.2.4 Global Felbamate Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Felbamate Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Felbamate Sales by Region
  9. 3.4.1 Global Felbamate Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Felbamate Sales by Region (2021-2026)
  11. 3.4.3 Global Felbamate Sales by Region (2027-2032)
  12. 3.4.4 Global Felbamate Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Felbamate Revenue by Manufacturers
  2. 4.1.1 Global Felbamate Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Felbamate Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Felbamate Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Felbamate Sales by Manufacturers
  6. 4.2.1 Global Felbamate Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Felbamate Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Felbamate Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Felbamate Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Felbamate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Felbamate Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Felbamate Manufacturers, Product Type & Application
  13. 4.7 Global Felbamate Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Felbamate Market CR5 and HHI
  16. 4.8.2 2025 Felbamate Tier 1, Tier 2, and Tier 3
5 Felbamate Market by Type
  1. 5.1 Global Felbamate Revenue by Type
  2. 5.1.1 Global Felbamate Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Felbamate Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Felbamate Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Felbamate Sales by Type
  6. 5.2.1 Global Felbamate Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Felbamate Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Felbamate Sales Market Share by Type (2021-2032)
  9. 5.3 Global Felbamate Price by Type
6 Felbamate Market by Application
  1. 6.1 Global Felbamate Revenue by Application
  2. 6.1.1 Global Felbamate Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Felbamate Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Felbamate Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Felbamate Sales by Application
  6. 6.2.1 Global Felbamate Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Felbamate Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Felbamate Sales Market Share by Application (2021-2032)
  9. 6.3 Global Felbamate Price by Application
7 Company Profiles
  1. 7.1 Sun Pharma
  2. 7.1.1 Sun Pharma Company Information
  3. 7.1.2 Sun Pharma Business Overview
  4. 7.1.3 Sun Pharma Felbamate Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharma Felbamate Product Portfolio
  6. 7.1.5 Sun Pharma Recent Developments
  7. 7.2 Mylan
  8. 7.2.1 Mylan Company Information
  9. 7.2.2 Mylan Business Overview
  10. 7.2.3 Mylan Felbamate Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Felbamate Product Portfolio
  12. 7.2.5 Mylan Recent Developments
  13. 7.3 Schering Plough
  14. 7.3.1 Schering Plough Company Information
  15. 7.3.2 Schering Plough Business Overview
  16. 7.3.3 Schering Plough Felbamate Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Schering Plough Felbamate Product Portfolio
  18. 7.3.5 Schering Plough Recent Developments
  19. 7.4 Merck Sharp and Dohme
  20. 7.4.1 Merck Sharp and Dohme Company Information
  21. 7.4.2 Merck Sharp and Dohme Business Overview
  22. 7.4.3 Merck Sharp and Dohme Felbamate Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Sharp and Dohme Felbamate Product Portfolio
  24. 7.4.5 Merck Sharp and Dohme Recent Developments
  25. 7.5 Corepharma
  26. 7.5.1 Corepharma Company Information
  27. 7.5.2 Corepharma Business Overview
  28. 7.5.3 Corepharma Felbamate Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Corepharma Felbamate Product Portfolio
  30. 7.5.5 Corepharma Recent Developments
  31. 7.6 Cadila Healthcare
  32. 7.6.1 Cadila Healthcare Company Information
  33. 7.6.2 Cadila Healthcare Business Overview
  34. 7.6.3 Cadila Healthcare Felbamate Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Cadila Healthcare Felbamate Product Portfolio
  36. 7.6.5 Cadila Healthcare Recent Developments
  37. 7.7 ANI Pharmaceuticals
  38. 7.7.1 ANI Pharmaceuticals Company Information
  39. 7.7.2 ANI Pharmaceuticals Business Overview
  40. 7.7.3 ANI Pharmaceuticals Felbamate Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 ANI Pharmaceuticals Felbamate Product Portfolio
  42. 7.7.5 ANI Pharmaceuticals Recent Developments
  43. 7.8 Amneal Pharmaceuticals
  44. 7.8.1 Amneal Pharmaceuticals Company Information
  45. 7.8.2 Amneal Pharmaceuticals Business Overview
  46. 7.8.3 Amneal Pharmaceuticals Felbamate Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Amneal Pharmaceuticals Felbamate Product Portfolio
  48. 7.8.5 Amneal Pharmaceuticals Recent Developments
  49. 7.9 Alvogen
  50. 7.9.1 Alvogen Company Information
  51. 7.9.2 Alvogen Business Overview
  52. 7.9.3 Alvogen Felbamate Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Alvogen Felbamate Product Portfolio
  54. 7.9.5 Alvogen Recent Developments
8 North America
  1. 8.1 North America Felbamate Market Size by Type
  2. 8.1.1 North America Felbamate Revenue by Type (2021-2032)
  3. 8.1.2 North America Felbamate Sales by Type (2021-2032)
  4. 8.1.3 North America Felbamate Price by Type (2021-2032)
  5. 8.2 North America Felbamate Market Size by Application
  6. 8.2.1 North America Felbamate Revenue by Application (2021-2032)
  7. 8.2.2 North America Felbamate Sales by Application (2021-2032)
  8. 8.2.3 North America Felbamate Price by Application (2021-2032)
  9. 8.3 North America Felbamate Market Size by Country
  10. 8.3.1 North America Felbamate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Felbamate Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Felbamate Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Felbamate Market Size by Type
  2. 9.1.1 Europe Felbamate Revenue by Type (2021-2032)
  3. 9.1.2 Europe Felbamate Sales by Type (2021-2032)
  4. 9.1.3 Europe Felbamate Price by Type (2021-2032)
  5. 9.2 Europe Felbamate Market Size by Application
  6. 9.2.1 Europe Felbamate Revenue by Application (2021-2032)
  7. 9.2.2 Europe Felbamate Sales by Application (2021-2032)
  8. 9.2.3 Europe Felbamate Price by Application (2021-2032)
  9. 9.3 Europe Felbamate Market Size by Country
  10. 9.3.1 Europe Felbamate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Felbamate Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Felbamate Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Felbamate Market Size by Type
  2. 10.1.1 China Felbamate Revenue by Type (2021-2032)
  3. 10.1.2 China Felbamate Sales by Type (2021-2032)
  4. 10.1.3 China Felbamate Price by Type (2021-2032)
  5. 10.2 China Felbamate Market Size by Application
  6. 10.2.1 China Felbamate Revenue by Application (2021-2032)
  7. 10.2.2 China Felbamate Sales by Application (2021-2032)
  8. 10.2.3 China Felbamate Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Felbamate Market Size by Type
  2. 11.1.1 Asia Felbamate Revenue by Type (2021-2032)
  3. 11.1.2 Asia Felbamate Sales by Type (2021-2032)
  4. 11.1.3 Asia Felbamate Price by Type (2021-2032)
  5. 11.2 Asia Felbamate Market Size by Application
  6. 11.2.1 Asia Felbamate Revenue by Application (2021-2032)
  7. 11.2.2 Asia Felbamate Sales by Application (2021-2032)
  8. 11.2.3 Asia Felbamate Price by Application (2021-2032)
  9. 11.3 Asia Felbamate Market Size by Country
  10. 11.3.1 Asia Felbamate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Felbamate Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Felbamate Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Felbamate Market Size by Type
  2. 12.1.1 SAMEA Felbamate Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Felbamate Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Felbamate Price by Type (2021-2032)
  5. 12.2 SAMEA Felbamate Market Size by Application
  6. 12.2.1 SAMEA Felbamate Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Felbamate Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Felbamate Price by Application (2021-2032)
  9. 12.3 SAMEA Felbamate Market Size by Country
  10. 12.3.1 SAMEA Felbamate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Felbamate Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Felbamate Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Felbamate Value Chain Analysis
  2. 13.1.1 Felbamate Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Felbamate Production Mode & Process
  6. 13.2 Felbamate Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Felbamate Distributors
  9. 13.2.3 Felbamate Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst